Crossref
The Practical Side Effects Experienced in Patients Treated With Medications Approved for Melanoma
Journal of Drugs in Dermatology · 2025
DOI: 10.36849/jdd.8368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Advaitaa Ravipati und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
MelanomaSkin NeoplasmsHumansMaleFemaleMiddle AgedAgedUnited StatesUnited States Food and Drug AdministrationIpilimumabImidazolesAdultAdverse Drug Reaction Reporting SystemsOximesNivolumabVemurafenibAged, 80 and overSex FactorsImmune Checkpoint Inhibitors
Substanzen
IpilimumabImidazolesOximesNivolumabVemurafenibdabrafenibImmune Checkpoint Inhibitors
Zitieren
APA
Ravipati, A., Pradeep, T., Jean-Pierre, P., & Nouri, K. (2025). The Practical Side Effects Experienced in Patients Treated With Medications Approved for Melanoma. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8368
Vancouver
Ravipati A, Pradeep T, Jean-Pierre P, Nouri K. The Practical Side Effects Experienced in Patients Treated With Medications Approved for Melanoma. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.8368
BibTeX
@article{Ravipati2025,
author = {Ravipati, Advaitaa and Pradeep, Tejus and Jean-Pierre, Philippe and Nouri, Keyvan},
title = {The Practical Side Effects Experienced in Patients Treated With Medications Approved for Melanoma},
journal = {Journal of Drugs in Dermatology},
year = {2025},
doi = {10.36849/jdd.8368}
}
EUVIMED